Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Tensions Escalate Between EU, AstraZeneca Over Vaccine Delivery

VOA News

   Tensions escalated Wednesday between the European Union and the
   British-Swedish drug maker AstraZeneca regarding the company's failure
   to meet a target to deliver 400 million doses of its COVD-19 vaccine to
   the regional bloc.

   The two sides had been scheduled to meet again Wednesday, to further
   discuss the issue but there are conflicting reports. EU officials had
   said the company backed out of the meeting and that it had been
   rescheduled for Thursday, but a company official later issued a
   statement saying the meeting was going to be held as scheduled
   Wednesday.
   The firm had signed a deal with the European Commission to supply 400
   million doses of its coronavirus vaccine, which is expected to get EU
   approval Friday.

.